MODEL VERDICT
KORU Medical Systems, Inc. (KRMD)
Relative Valuation•Peer multiples, Monte Carlo simulation & quality-adjusted fair value
Popular:
Composite score derived from valuation, quality, and risk factors
Quantitative model thresholds · For educational and research purposes only
| Methodology | Fair Value | vs Current | Weight | Quality | Status |
|---|---|---|---|---|---|
| EV To Revenue 37 industry peers | $2.91 | -39.1% | 4% | B | Data |
| Price / Sales 38 industry peers | $2.58 | -46.0% | 3% | B | Model Driven |
| Weighted Output Blended model output | $3.17 | -33.6% | 100% | 58 | SIGNIFICANTLY OVERVALUED |
Cross-sectional regression predicting expected multiples based on growth, margins, ROIC, and beta.
| Multiple | Avg | Median | Min | Max | Std |
|---|---|---|---|---|---|
| EV/EBIT | 93.55 | 62.37 | 29.31 | 188.98 | 84.28 |
| P/TBV | 9.29 | 7.15 | 3.73 | 24.46 | 7.07 |
| P/B Ratio | 8.80 | 6.98 | 3.65 | 22.70 | 6.49 |
| P/S Ratio | 6.54 | 5.67 | 3.70 | 11.01 | 2.98 |
Based on our peer multiples analysis with 5 valuation metrics, the model estimates KRMD's fair value at $3.17 vs the current price of $4.78, implying -33.6% downside potential. Model verdict: Significantly Overvalued. Confidence: 58/100. This is a quantitative estimate, not a recommendation.
The blended fair value of $3.17 is calculated using four lenses: industry median multiples (40%), historical multiples (30%), forward estimates (20%), and quality-adjusted multiples (10%). Monte Carlo simulation (10,000 iterations) gives a range of $2.16 (P10) to $4.54 (P90), with a median of $3.34.
KRMD's current P/E of -36.8x compares to the industry median of 33.6x (18 peers in the group). This represents a -209.5% discount to the industry. The historical average P/E is N/Ax over 0 years. Signal: Deep Discount.
5 analysts cover KRMD with a consensus rating of Buy. The consensus price target is $7.00 (range: $6.00 — $8.00), implying +46.4% upside from the current price. Grade breakdown: Strong Buy (0), Buy (4), Hold (1), Sell (0), Strong Sell (0).
The model confidence score is 58/100, based on: data completeness (6), peer quality (25), historical depth (20), earnings stability (5), and model agreement (2). Cyclicality penalty: -0 points. The model shows moderate agreement across inputs.
The model flags several key risks: (1) Macro/regulatory risks are not captured in this model but remain material.
Peak earnings risk data is not available for KRMD.
No. This dashboard is a quantitative research tool for educational and informational purposes only. It is not investment advice, a solicitation, or a recommendation to buy, sell, or hold any security. The operator of this platform is not a registered investment advisor (RIA), broker-dealer, or financial planner. All model outputs, fair value estimates, signals, and scenarios are the result of automated quantitative computations and should not be construed as professional financial guidance. You should consult a qualified, licensed financial advisor before making any investment decisions. Past model performance is not indicative of future results.